AtriCure (ATRC) Stock: Why It's Down Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $55.63 as of 12:05 PM ET, -0.78% vs the prior close of $56.07.
- Volume 119.50K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ATRC dips 0.8% to $55.63. Trading at $55.63 (intraday, 12:05 PM ET), -0.78% vs the prior close of $56.07. Day range $55.16–$56.31, opened at $55.75.
ATRC daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — ATRC dips 0.8% to $55.63
- Trading at $55.63 (intraday, 12:05 PM ET), -0.78% vs the prior close of $56.07. Day range $55.16–$56.31, opened at $55.75.
- Volume was 119.50K shares, 0.1x its 50-day average of 1.10M — lighter than usual.
- Price is +5.4% vs its 50-day average ($52.79) and +49.7% vs its 200-day average ($37.17).
- 52-week range $25.36–$61.70; the current price sits at 83% of that range, 9.8% below the 52-week high.
Oct 16, 2026 — ATRC dips 3.0% to $56.07
- Closed at $56.07, -2.96% vs the prior close of $57.78. Day range $55.90–$58.31, opened at $57.98.
- Volume was 648.24K shares, 0.6x its 50-day average of 1.10M — lighter than usual.
- Price is +6.8% vs its 50-day average ($52.51) and +51.2% vs its 200-day average ($37.09).
- 52-week range $25.36–$61.70; today's close sits at 85% of that range, 9.1% below the 52-week high.
Oct 15, 2026 — ATRC rises 0.8% to $57.78
- Closed at $57.78, +0.84% vs the prior close of $57.30. Day range $56.27–$58.44, opened at $57.83.
- Volume was 850.90K shares, 0.8x its 50-day average of 1.10M.
- Price is +10.7% vs its 50-day average ($52.17) and +56.1% vs its 200-day average ($37.01).
- 52-week range $25.36–$61.70; today's close sits at 89% of that range, 6.4% below the 52-week high.
Oct 14, 2026 — ATRC rises 0.8% to $57.30
- Closed at $57.30, +0.76% vs the prior close of $56.87. Day range $55.84–$57.89, opened at $56.13.
- Volume was 799.30K shares, 0.7x its 50-day average of 1.10M.
- Price is +10.6% vs its 50-day average ($51.81) and +55.2% vs its 200-day average ($36.92).
- 52-week range $25.36–$61.70; today's close sits at 88% of that range, 7.1% below the 52-week high.
Oct 13, 2026 — ATRC dips 0.7% to $56.87
- Closed at $56.87, -0.72% vs the prior close of $57.28. Day range $56.39–$57.98, opened at $57.60.
- Volume was 596.10K shares, 0.5x its 50-day average of 1.11M — lighter than usual.
- Price is +10.6% vs its 50-day average ($51.44) and +54.4% vs its 200-day average ($36.84).
- 52-week range $25.36–$61.70; today's close sits at 87% of that range, 7.8% below the 52-week high.
Oct 12, 2026 — ATRC rises 2.6% to $57.28
- Closed at $57.28, +2.63% vs the prior close of $55.81. Day range $55.67–$57.35, opened at $56.29.
- Volume was 645.60K shares, 0.6x its 50-day average of 1.12M — lighter than usual.
- Price is +12.1% vs its 50-day average ($51.08) and +55.8% vs its 200-day average ($36.76).
- 52-week range $25.36–$61.70; today's close sits at 88% of that range, 7.2% below the 52-week high.
Oct 9, 2026 — ATRC jumps 5.6% to $55.81
- Closed at $55.81, +5.62% vs the prior close of $52.84. Day range $52.44–$55.89, opened at $53.14.
- Volume was 712.50K shares, 0.6x its 50-day average of 1.13M.
- Price is +10.1% vs its 50-day average ($50.69) and +52.2% vs its 200-day average ($36.67).
- 52-week range $25.36–$61.70; today's close sits at 84% of that range, 9.5% below the 52-week high.
Oct 8, 2026 — ATRC dips 0.9% to $52.84, a 1-month low, 3 down days in a row
- Closed at $52.84, -0.88% vs the prior close of $53.31. Day range $51.63–$53.46, opened at $53.07.
- Volume was 595.60K shares, 0.5x its 50-day average of 1.14M — lighter than usual.
- Price is +4.9% vs its 50-day average ($50.37) and +44.4% vs its 200-day average ($36.60).
- 52-week range $25.36–$61.70; today's close sits at 76% of that range, 14.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ATRC dips 0.7% to $53.31
- Closed at $53.31, -0.69% vs the prior close of $53.68. Day range $52.98–$54.88, opened at $53.35.
- Volume was 753.50K shares, 0.7x its 50-day average of 1.15M.
- Price is +6.3% vs its 50-day average ($50.13) and +45.9% vs its 200-day average ($36.54).
- 52-week range $25.36–$61.70; today's close sits at 77% of that range, 13.6% below the 52-week high.
Oct 6, 2026 — ATRC slides 4.8% to $53.68
- Closed at $53.68, -4.77% vs the prior close of $56.37. Day range $53.43–$56.58, opened at $55.97.
- Volume was 863.70K shares, 0.7x its 50-day average of 1.15M.
- Price is +7.7% vs its 50-day average ($49.86) and +47.2% vs its 200-day average ($36.48).
- 52-week range $25.36–$61.70; today's close sits at 78% of that range, 13.0% below the 52-week high.
Oct 5, 2026 — ATRC rises 2.2% to $56.37
- Closed at $56.37, +2.23% vs the prior close of $55.14. Day range $53.86–$56.60, opened at $54.14.
- Volume was 1.10M shares, 0.9x its 50-day average of 1.17M.
- Price is +13.8% vs its 50-day average ($49.54) and +54.8% vs its 200-day average ($36.41).
- 52-week range $25.36–$61.70; today's close sits at 85% of that range, 8.6% below the 52-week high.
Oct 2, 2026 — ATRC rises 2.9% to $55.14
- Closed at $55.14, +2.89% vs the prior close of $53.59. Day range $52.00–$55.25, opened at $52.51.
- Volume was 1.62M shares, 1.4x its 50-day average of 1.16M.
- Price is +12.3% vs its 50-day average ($49.11) and +51.7% vs its 200-day average ($36.34).
- 52-week range $25.36–$61.70; today's close sits at 82% of that range, 10.6% below the 52-week high.
ATRC bull case vs bear case (from the data)
- Price is +5.4% vs its 50-day average — short-term trend is up.
- Price is +49.7% vs its 200-day average — above the long-term trend line.
- Annual revenue grew 14.9% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $11.45M.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
ATRC latest news & SEC filings
Every SEC filing by or about ATRC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Privitera Salvatore sold 4,519 shares at $60.00 (≈$271.14K) on Sep 23, 2026; now holds 142,745
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 23, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Groves Regina E sold 5,313 shares at $54.22 (≈$288.07K) on Sep 11, 2026
- Groves Regina E sold 5,313 shares at $54.22 (≈$288.07K) on Sep 11, 2026
- Groves Regina E sold 5,313 shares at $54.22 (≈$288.07K) on Sep 11, 2026
- Groves Regina E sold 5,313 shares at $54.22 (≈$288.07K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Privitera Salvatore sold 3,657 shares at $55.00 (≈$201.13K) on Sep 8, 2026
- Privitera Salvatore sold 3,657 shares at $55.00 (≈$201.13K) on Sep 8, 2026
- Privitera Salvatore sold 3,657 shares at $55.00 (≈$201.13K) on Sep 8, 2026
- Privitera Salvatore sold 3,657 shares at $55.00 (≈$201.13K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 27, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 27, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 27, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $153.60M (prior year $136.14M) (+12.8% vs Jun 30, 2025)
- Net income: $8.96M (prior year -$6.19M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.18 (prior year -$0.13) (swung to profit vs Jun 30, 2025)
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade ATRC
- Last results release: Jul 23, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Feb 17, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Oct 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.12% (largest 5.6%).
- Liquidity: about 969.51K shares (≈$53.93M) trade per day on average.
- 52-week position: $55.63 vs a range of $25.36–$61.70 (83% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Salvatore Privitera sold 4,519 shares on Sep 23, 2026.
- Latest filings: 10-Q Jul 27, 2026; 8-K Jul 23, 2026; 8-K May 19, 2026.
- Share count: 50.87M shares outstanding (Jul 22, 2026), +2.3% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ATRC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 55.75 | 56.31 | 55.16 | 55.63 | 119.50K |
| Oct 16, 2026 | 57.98 | 58.31 | 55.90 | 56.07 | 648.30K |
| Oct 15, 2026 | 57.83 | 58.44 | 56.27 | 57.78 | 850.90K |
| Oct 14, 2026 | 56.13 | 57.89 | 55.84 | 57.30 | 799.30K |
| Oct 13, 2026 | 57.60 | 57.98 | 56.39 | 56.87 | 596.10K |
| Oct 12, 2026 | 56.29 | 57.35 | 55.67 | 57.28 | 645.60K |
| Oct 9, 2026 | 53.14 | 55.89 | 52.44 | 55.81 | 712.50K |
| Oct 8, 2026 | 53.07 | 53.46 | 51.63 | 52.84 | 595.60K |
| Oct 7, 2026 | 53.35 | 54.88 | 52.98 | 53.31 | 753.50K |
| Oct 6, 2026 | 55.97 | 56.58 | 53.43 | 53.68 | 863.70K |
| Oct 5, 2026 | 54.14 | 56.60 | 53.86 | 56.37 | 1.10M |
| Oct 2, 2026 | 52.51 | 55.25 | 52.00 | 55.14 | 1.62M |
| Oct 1, 2026 | 56.52 | 56.99 | 52.60 | 53.59 | 1.97M |
| Sep 30, 2026 | 58.01 | 58.60 | 56.15 | 56.20 | 1.11M |
| Sep 29, 2026 | 58.58 | 59.05 | 56.59 | 58.05 | 876.30K |
| Sep 28, 2026 | 57.56 | 58.49 | 56.90 | 58.41 | 1.16M |
| Sep 25, 2026 | 60.85 | 61.32 | 57.89 | 58.38 | 1.59M |
| Sep 24, 2026 | 59.63 | 61.70 | 59.13 | 60.77 | 1.30M |
| Sep 23, 2026 | 58.92 | 61.48 | 58.72 | 59.96 | 1.21M |
| Sep 22, 2026 | 58.62 | 59.69 | 57.94 | 58.83 | 871.60K |
About AtriCure
AtriCure (ATRC) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MASON, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1323885.
ATRC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael H Carrel | President, CEO, & Director | Aug 3, 2026 |
| Regina E Groves | Director | Sep 14, 2026 |
| B Kristine Johnson | Director | May 20, 2026 |
| Shlomo Nachman | Director | May 20, 2026 |
| Karen Prange | Director | Aug 7, 2026 |
| Deborah H Telman | Director | May 20, 2026 |
| Sven Wehrwein | Director | Jul 30, 2026 |
| Robert S. White | Director | May 20, 2026 |
| Maggie Yuen | Director | Aug 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael H Carrel | President, CEO, & Director | Aug 3, 2026 |
| Karl S. Dahlquist | Chief Legal Officer | Aug 26, 2026 |
| Vinayak Doraiswamy | Chief Scientific Officer | Jul 30, 2026 |
| Justin J Noznesky | Chief Mktg & Strategy Officer | Jul 30, 2026 |
| Salvatore Privitera | Chief Technical Officer | Sep 24, 2026 |
| Douglas J Seith | Chief Operating Officer | Jul 2, 2026 |
| Angela L Wirick | Chief Financial Officer | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2026 | Salvatore Privitera | Sale | 4,519 | $60.00 |
| Sep 23, 2026 | Salvatore Privitera | Sale | 4,519 | $60.00 |
| Sep 23, 2026 | Salvatore Privitera | Sale | 4,519 | $60.00 |
| Sep 23, 2026 | Salvatore Privitera | Sale | 4,519 | $60.00 |
| Sep 11, 2026 | Regina E Groves | Sale | 5,313 | $54.22 |
| Sep 11, 2026 | Regina E Groves | Sale | 5,313 | $54.22 |
| Sep 11, 2026 | Regina E Groves | Sale | 5,313 | $54.22 |
| Sep 11, 2026 | Regina E Groves | Sale | 5,313 | $54.22 |
| Sep 8, 2026 | Salvatore Privitera | Sale | 3,657 | $55.00 |
| Sep 8, 2026 | Salvatore Privitera | Sale | 3,657 | $55.00 |
| Sep 8, 2026 | Salvatore Privitera | Sale | 3,657 | $55.00 |
| Sep 8, 2026 | Salvatore Privitera | Sale | 3,657 | $55.00 |
| Sep 2, 2026 | Salvatore Privitera | Sale | 7,763 | $52.50 |
| Sep 2, 2026 | Salvatore Privitera | Sale | 7,763 | $52.50 |
| Sep 2, 2026 | Salvatore Privitera | Sale | 7,763 | $52.50 |
ATRC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $534.53M | $-11.45M | -0.24 | $57.33M |
| Dec 31, 2024 | $465.31M | $-44.70M | -0.95 | $12.20M |
| Dec 31, 2023 | $399.25M | $-30.44M | -0.66 | $4.48M |
| Dec 31, 2022 | $330.38M | $-46.47M | -1.02 | $-22.14M |
| Dec 31, 2021 | $274.33M | $50.20M | 1.09 | $-13.78M |
Latest balance sheet: total assets $676.64M, total liabilities $160.21M, cash $167.79M (as of Jun 30, 2026).
ATRC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 23, 2026 | 8-K Item 2.02 (results) | $33.00 |
| May 5, 2026 | 8-K Item 2.02 (results) | $29.39 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $32.97 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $37.64 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $35.44 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $31.73 |
| Apr 29, 2025 | 8-K Item 2.02 (results) | $34.65 |
| Feb 12, 2025 | 8-K Item 2.02 (results) | $42.36 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $34.39 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $29.43 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| May 1, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on ATRC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.